| scholarly article | Q13442814 |
| P356 | DOI | 10.1046/J.1365-2141.2003.04795.X |
| P8608 | Fatcat ID | release_bsbb37y6hncchekvd6npqevu7a |
| P698 | PubMed publication ID | 14984502 |
| P5875 | ResearchGate publication ID | 8683968 |
| P2093 | author name string | Cini Michela | |
| Cosmi Benilde | |||
| Frascaro Mirella | |||
| Guazzaloca Giuliana | |||
| Legnani Cristina | |||
| Palareti Gualtiero | |||
| P2860 | cites work | Elevated factor VIII levels and the risk of thrombosis | Q34248938 |
| Mutation in blood coagulation factor V associated with resistance to activated protein C. | Q34340007 | ||
| Factor VIII activity as measured by an amidolytic assay compared with a one-stage clotting assay | Q41772095 | ||
| Genetic determinants of hemostasis phenotypes in Spanish families. | Q54056926 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | venous thromboembolism | Q9397786 |
| P304 | page(s) | 504-510 | |
| P577 | publication date | 2004-02-01 | |
| P1433 | published in | British Journal of Haematology | Q4970200 |
| P1476 | title | High plasma levels of factor VIII and risk of recurrence of venous thromboembolism | |
| P478 | volume | 124 |
| Q56997786 | Abnormally short activated partial thromboplastin time values are associated with increased risk of recurrence of venous thromboembolism after oral anticoagulation withdrawal |
| Q35987865 | Association between micro particle-tissue factor activity, factor VIII activity and recurrent VTE in patients with acute pulmonary embolism |
| Q50782352 | D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolism. |
| Q36030521 | Elevated clotting factor levels and venous thrombosis |
| Q34270700 | Elevated factor VIII levels and risk of venous thrombosis. |
| Q53481948 | Evolving presentation of leg cramps in a child with nephrotic syndrome: Answers. |
| Q45856102 | Fatal postoperative pulmonary embolism in mild haemophilia |
| Q37877279 | Guideline on the investigation, management and prevention of venous thrombosis in children |
| Q35525678 | Heparin and warfarin anticoagulation intensity as predictors of recurrence after deep vein thrombosis or pulmonary embolism: a population-based cohort study |
| Q21093254 | Hereditary thrombophilia |
| Q40129111 | High coagulation factor VIII and von Willebrand factor in patients with lymphoma and leukemia |
| Q38263114 | How D-dimer assay can be useful in deciding the duration of anticoagulation after venous thromboembolism: a review |
| Q46770296 | Idiopathic intracranial hypertension: associations with thrombophilia and hypofibrinolysis in men. |
| Q28387350 | Inflammation and coagulation markers and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA) |
| Q39611973 | Markers of coagulation, fibrinolysis and inflammation in relation to post-thrombotic syndrome |
| Q57823773 | Measurement of coagulation factors during rivaroxaban and apixaban treatment: Results from two crossover trials |
| Q47959251 | Optimal long-term pharmacological treatment of patients with venous thromboembolism that was unprovoked or associated with weak risk factors |
| Q91979008 | Pathophysiology 1. Mechanisms of Thrombosis in Cancer Patients |
| Q46470692 | Poor anticoagulation quality in the first 3 months after unprovoked venous thromboembolism is a risk factor for long-term recurrence. |
| Q42058402 | Post splenectomy fatal pulmonary embolism in a patient with moderate hemophilia a. |
| Q61816605 | Predicting VTE in Cancer Patients: Candidate Biomarkers and Risk Assessment Models |
| Q26865059 | Predicting the risk of venous thromboembolism recurrence |
| Q41486100 | Predictive value of factor VIII levels for recurrent venous thrombosis: results from the MEGA follow-up study. |
| Q35920759 | Predictors of venous thromboembolism recurrence, adjusted for treatments and interim exposures: a population-based case-cohort study |
| Q26826847 | Recurrent venous thromboembolism: what is the risk and how to prevent it |
| Q34153343 | Risk assessment for recurrent venous thrombosis |
| Q86113807 | Thrombin generation in Cushing's Syndrome: do the conventional clotting indices tell the whole truth? |
| Q38365992 | Thrombophilia: clinical-practical aspects |
| Q37892665 | Using the laboratory to predict recurrent venous thrombosis |
| Q38117733 | Venous thrombosis: understanding the paradoxes of recurrence |
Search more.